Stay updated on IMO-2125 Combo With Ipilimumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the IMO-2125 Combo With Ipilimumab in Melanoma Clinical Trial page.

Latest updates to the IMO-2125 Combo With Ipilimumab in Melanoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedIntroducing a major status notice about government funding and NIH Clinical Center operations (including links to official sources) and updating the page version from v3.1.0 to v3.2.0.SummaryDifference3%
- Check23 days agoChange DetectedUpdated the page to reflect a newer software version (from v3.0.2 to v3.1.0); the old version tag was removed and a new one added. This is a metadata/versioning update rather than substantive content change.SummaryDifference0.1%
- Check38 days agoChange DetectedUpdated revision from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.2%
- Check45 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.2%
- Check52 days agoChange DetectedThe web page has added significant content related to various proteins and antibodies, including specific types and their relevance to skin and connective tissue diseases, while removing several references to locations and genetic disease resources.SummaryDifference3%
- Check66 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to IMO-2125 Combo With Ipilimumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMO-2125 Combo With Ipilimumab in Melanoma Clinical Trial page.